From Follower to Force: China's Biotech Sector Enters the Global Clinical Mainstream
PR Newswire —
WASHINGTON, Dec. 26, 2025 /PRNewswire/ -- Over the past decade, China has evolved from a biotechnology follower into an increasingly influential global innovator. Once reliant on Western pharmaceutical companies for advanced therapies, the country is now building a homegrown biotech...